课题基金 / 基金详情

Medical Scientist Training Program

Medical Scientist Training Program
医学科学家培训计划
批准号:
10715841
负责人:
DIANNA M MILEWICZ
金额:
$52.41万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-23 至 2028-06-30

项目摘要

项目成果

DIANNA M MILEWICZ的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结 我们的多机构MSTP的使命是由德克萨斯大学健康科学学院组成 休斯顿大学健康中心(UTHealth Houston),德克萨斯大学MD安德森癌症中心 (MDACC),并与波多黎各大学医学校园合作 医学院(UPR),是追求一种不同的智力天赋群体的新培训 以医生为职业的学生-科学家专注于面向疾病的研究和桥梁 医学和基础科学之间的知识鸿沟。MSTP一直在持续 自1982年成立以来,已有136名学生毕业。为了扩大我们内科科学家的多样性 受训人员,我们已经与普遍定期审议合作,利用NIH资助的MDACC/UPR U54 癌症研究卓越合作伙伴奖将把那些有才华的人纳入我们的MSTP 希望从事研究事业的UPR医学生,我们大约34%的学生 方案是代表不足的少数族裔(URM)。来自中国的学生申请参加我们的项目 在过去的10年里翻了一番,使我们能够招收一批 高资质学生(目前有50名学生在该项目中)。为内科科学家做好准备 为了追求以疾病为导向的研究,建立了一种新的教育序列,以整合 医学院和研究生院。尽管学生们开始满足研究生的要求 从项目一开始,他们就完成了临床专业的轮换 从事学位论文研究。学生可以从9个研究生培训计划中进行选择 生物医学科学。对这一教育顺序的支持是由以下事实提供的:在 在过去的10年里,该计划的人员流失率不到4%,完成该计划的时间为7.8 好几年了。我们的学生在研究道德以及严谨和可重复性方面都得到了广泛的培训 以及如何在安全的研究环境中工作。学生的质量和计划是 以强劲的出版记录和出色的常驻匹配为例。一个主要因素是 加强培训是分子医学课程的必修课,它提供了垂直的 学生的融合和社区,接触到研究的广度和深度 机构,以及对职业发展和领导力的洞察。基于多年来的毕业生 在过去的15年里,我们大部分毕业的毕业生都留在了与研究相关的领域 职业(71%;学术界、FDA、生物技术;n=30)。总共需要6个MSTP支持 每年招生扩大招生人数在这方面独树一帜,形式多样 培训计划。
英文摘要
PROJECT SUMMARY The mission of our multi-institutional MSTP, comprised of The University of Texas Health Science Center at Houston (UTHealth Houston), The University of Texas MD Anderson Cancer Center (MDACC), and in conjunction with The University of Puerto Rico Medical Sciences Campus School of Medicine (UPR), is to pursue novel training of a diverse group of intellectually gifted students for careers as physician-scientists focused on disease-oriented research and bridging the knowledge gap between medicine and basic science. The MSTP has been continuously funded since 1982 and has graduated 136 students. To expand diversity in our physician-scientist trainees, we have partnered with the UPR, leveraging a NIH-funded MDACC/UPR U54 Partnership for Excellence in Cancer Research award to integrate into our MSTP those talented UPR medical students who want to pursue research careers, and approximately 34% of our program is underrepresented minorities (URM). Applications to our program from students from across the country have doubled over the past 10 years, allowing us to matriculate a group of highly qualified students (50 students currently in the program). To prepare physician-scientists to pursue disease-oriented research, a novel educational sequence was established to integrate the medical and graduate school. Although students begin to fulfill graduate school requirements from the very beginning of the program, they complete the clinical specialty rotations before pursuing dissertation research. Students can select from 9 graduate training programs in biomedical sciences. Support for this educational sequence is provided by the fact that, in the past 10 years, attrition from the program has been less than 4% and the time to completion is 7.8 years. Our students get extensive training in ethics of research and in rigor and reproducibility as well as how to work in a safe research environment. The quality of students and the program are exemplified by strong publication records and excellent residency matches. A major element to enhance training is the required Topics in Molecular Medicine course, which provides vertical integration and community for the students, exposure to the breadth and depth of research at the institutions, and insights into career development and leadership. Based on graduates over the past 15 years, the majority of our graduates who are out of training stayed in research-related careers (71%; academia, FDA, Biotech; n = 30). MSTP support is requested for a total of 6 matriculating students per year to expand the number of students in this unique and diverse training program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2023 Elastin, Elastic Fibers and Microfibrils Gordon Research Conference and Gordon Research Seminar
  • 批准号:
    10754079
  • 项目类别:
  • 资助金额:
    $3.01万
  • 财政年份:
    2023
  • 负责人:
    DIANNA M MILEWICZ
  • 依托单位:
Novel genetic Insight into the molecular pathogenesis of atherosclerosis
Novel genetic Insight into the molecular pathogenesis of atherosclerosis
Novel genetic Insight into the molecular pathogenesis of atherosclerosis
海外基金